![]() |
Volumn 52, Issue 3, 2008, Pages 901-908
|
The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABACAVIR;
ADEFOVIR;
AMPRENAVIR;
ATAZANAVIR;
DELAVIRDINE;
DIDANOSINE;
EFAVIRENZ;
EMTRICITABINE;
ENFUVIRTIDE;
GSK 304649;
GSK 364735;
INDINAVIR;
INTEGRASE INHIBITOR;
LAMIVUDINE;
LOPINAVIR;
NELFINAVIR;
NEVIRAPINE;
PROTEINASE;
RIBAVIRIN;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE;
SAQUINAVIR;
STAVUDINE;
TENOFOVIR;
UNCLASSIFIED DRUG;
ZALCITABINE;
ZIDOVUDINE;
ANTIVIRAL ACTIVITY;
ARTICLE;
BINDING AFFINITY;
CELL ASSAY;
CONTROLLED STUDY;
DNA INTEGRATION;
DRUG POTENTIATION;
DRUG STRUCTURE;
DRUG TARGETING;
ENZYME ACTIVE SITE;
ENZYME INHIBITION;
HUMAN;
HUMAN CELL;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HYDROPHOBICITY;
IC 50;
LONG TERMINAL REPEAT;
METAL BINDING;
PERIPHERAL BLOOD MONONUCLEAR CELL;
PRIORITY JOURNAL;
VIRUS REPLICATION;
VIRUS RESISTANCE;
ANTI-HIV AGENTS;
CELL LINE;
CELLS, CULTURED;
DRUG RESISTANCE, VIRAL;
DRUG SYNERGISM;
HIV INTEGRASE;
HIV INTEGRASE INHIBITORS;
HIV PROTEASE INHIBITORS;
HIV-1;
HUMANS;
LEUKOCYTES, MONONUCLEAR;
MICROBIAL SENSITIVITY TESTS;
MUTATION;
NAPHTHYRIDINES;
REVERSE TRANSCRIPTASE INHIBITORS;
VIRUS INTEGRATION;
VIRUS REPLICATION;
|
EID: 40549145842
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/AAC.01218-07 Document Type: Article |
Times cited : (74)
|
References (32)
|